Navigation Links
Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
Date:6/24/2009

Seventy-Seven Percent of Surveyed Physicians Will Increase Their Use of Carbapenems In the Next Five Years, According to a New Report from AMR and Decision Resources

MALVERN, Pa. and WALTHAM, Mass., June 24 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that availability in both intravenous and oral formulation is a leading drug attribute that surveyed physicians prefer for the treatment of complicated urinary tract infections (UTIs) in the hospital setting. Antibiotics available in interchangeable oral and parenteral formulations can facilitate step-down therapy and discharge from the hospital to the outpatient setting.

"Physicians prescribe a wide variety of antibiotics for UTIs, mainly from the quinolone and cephalosporin classes," stated Lisa Arias, analyst at Decision Resources. "These broad-spectrum agents are popular first-line agents in UTIs, and oral quinolones, in particular, have become a popular choice for first-line, step-down and discharge therapy."

The new report entitled Hospital Anti-Infectives Insight Series: Urinary Tract Infections also finds that extended-spectrum beta-lactamase-producing and quinolone-resistant gram-negative pathogens are among the most concerning pathogens, and that 77 percent of surveyed physicians expect to increase their prescribing of carbapenems for complicated UTIs in the next five years. These potent, broad-spectrum antibiotics are especially useful for treating gram-negative infections involving resistant organisms.

About Hospital Anti-Infectives Insight Series

AMR and Decision Resources' Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with Decision Resources' disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts. These reports examine the reasons behind physicians' product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

About AMR

AMR (www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:
    Gisselle Morales
    Decision Resources
    781-296-2691
    gmorales@dresources.com

    Elizabeth Marshall
    Decision Resources, Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Decision Resources; Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
2. LMS integrated obstetrics solution achieves general availability
3. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
4. PA Breast Cancer Coalition Announces Special Press Availability for PA Breast Cancer Coalition Annual Conference
5. Pelosi to Hold Press Availability with SCHIP Family Tomorrow Morning
6. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
7. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
8. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
9. Visage Imaging Expands Availability of Its Advanced Visualization Offering
10. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
11. Dblur Announces the Availability of a Software Lens(TM) Enabled Chip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: